Skip to content
thestock.space

On 6 Nov 2026, Apollo Hospitals Enterprise was priced at ₹8,446.00, or 54.0× trailing earnings, against an industry P/E of 47.7×. Sales and net profit grew 15% and 33% a year over 3 years; its ROCE of 19% is the highest among the 7 largest Medical Care Facilities peers. Debt is 0.73× equity, and its dividend yield is 0.2%. It is a large-cap company with a market cap of ₹1.2 lakh crore, the largest of 40 Medical Care Facilities companies by market cap; the shares rose 7.2% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹8,356.00
Day high
₹8,481.00
Day low
₹8,310.00
Prev. close
₹8,371.00
Volume
4.2 L

Health check

2 good · 4 fair
  • ReturnsAhead

    +7.2% over a year, better than 6 of 7 peers.

  • Price tagIn line

    P/E 54.0 vs industry 47.7.

  • GrowthSteady

    Sales +14.8%, profit +33.3% a year over 3 years.

  • ProfitabilityAverage

    ROCE 19.2% vs peer median 11.4%.

  • Balance sheetFair

    Debt 0.73× equity, interest covered 8.5×, Piotroski 7 of 9.

  • Red flagsNone found

    No warning signs in the headline numbers.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Large cap

₹1.2L Cr, the largest of 40 in its industry.

Defensive

Beta 0.25 vs the NIFTY 50: moves less than the market.

Key metrics

Last 12 months to Sep 2026: sales ₹27,852 Cr · profit ₹2,238 Cr
Market cap
₹1.2L Cr
Large cap
P/E
54.0
Industry 47.7
Price to book
11.45
Peers 8.06
Dividend yield
0.24%
ROE
22.5%
Peers 11.0%
ROCE
19.2%
Peers 11.4%
Debt to equity
0.73
Debt ₹8,149 Cr
EPS (TTM)
₹156.39
Face value ₹5
OPM (TTM)
15.4%
Net margin 8.1%
Sales growth
+23.0%
Latest quarter vs a year ago
Profit growth
+31.9%
Latest quarter vs a year ago
Price to sales
4.36
EV/EBITDA 32.4

Strengths and risks

Strengths

  • Return on equity of 22.5%.
  • Quarterly profit up 31.9% on a year ago.
  • Quarterly sales up 23.0% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

No obvious red flags in the headline numbers.

Derived automatically from reported figures. Not a recommendation.

About Apollo Hospitals Enterprise

Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics,…

Headquarters
Chennai
Employees
44,008
Sector
Healthcare
ISIN
INE437A01024
Website
apollohospitals.com

Price range

52 weeks

₹6,696.50₹9,070.50

Today

₹8,310.00₹8,481.00
Avg volume (3M)
5.1 L
1-year return
plus 7.2%
From 52-week high
minus 6.9%

Analyst consensus

30 analysts
Strong buyMean target ₹9,811.43 plus 16.2%

Target range, with today’s price

Low ₹6,230.00High ₹10,800.00

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.89%57,89866.18.0611.4%11.0%19.8%18.8%9.6%0.13%2.0%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
6,1896,4776,6067,0447,615
5,2645,5125,5955,9516,424
9249651,0111,0921,191
14.9%14.9%15.3%15.5%15.6%
60.867.75462.256.7
98.6113119120114
205219224235230
–−19.2–––
681682722799903
–24.3%23.6%23.6%27.1%
–502529581630
33.2034.9436.7640.3743.79

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+14.8%
Profit CAGR 3Y
+33.3%
EPS CAGR 3Y
+33.3%
ROE
22.5%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
16,44518,86221,52724,911
–+14.7%+14.1%+15.7%
14,38016,46818,49321,131
2,0652,3943,0333,779
12.6%12.7%14.1%15.2%
−5.347.611555.8
314410423356
615687758876
13.535.771.158
1,1441,3812,0392,661
22.4%32.3%26.2%24.7%
8198991,4461,942
–+9.7%+60.9%+34.3%
56.9762.50100.56134.94

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
71.971.971.971.9
6,1266,8648,1409,408
4,3325,3335,4198,493
3,8984,4857,0264,224
14,42816,75320,65722,197
8,1179,46110,73912,228
6859219231,190
2531448791,080
7261,1902,0101,856
4,6475,0386,1065,843
14,42816,75320,65722,197

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1,3771,9202,1362,856
−871−1,537−3,383−2,148
−633−3111,319−478
−12771.972.6230
−1,129−1,137−1,713−1,962
248783424894
−255−216−273−288

Shareholding pattern

Source: NSE filings
28.0%
promoters
  • Promoters28.02%
  • Public71.98%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202628.02%71.98%0.00
30 Jun 202628.02%71.98%0.00
31 Mar 202628.02%71.98%0.00
31 Dec 202528.02%71.98%0.00
30 Sep 202528.02%71.98%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you